|
인쇄하기
취소
|
Sanofi-Synthelabo launches Cronosphere, innovative anti-epileptic drug
Published: 2004-06-09 06:57:00
Updated: 2004-06-09 06:57:00
Sanofi-Synthelabo said it has launched Cronosphere, a novel dosage form of Depakine (sodium valproate) for the treatment of epilepsy.
Cronosphere is a sustained release dosage form using a prilling method.
Spherical microbeads of uniform size are widely used in the pharmaceutical industry, where well-known and reproducible operation conditions are important to characterize the process an...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.